Literature DB >> 10409198

Pathways of HERG inactivation.

J Kiehn1, A E Lacerda, A M Brown.   

Abstract

The rapid, repolarizing K(+) current in cardiomyocytes (I(Kr)) has unique inwardly rectifying properties that contribute importantly to the downstroke of the cardiac action potential. The human ether-à-go-go-related gene (HERG) expresses a macroscopic current virtually identical to I(Kr), but a description of the single-channel properties that cause rectification is lacking. For this reason we measured single-channel and macropatch currents heterologously expressed by HERG in Xenopus oocytes. Our experiments had two main findings. First, the single-channel current-voltage relation showed inward rectification, and conductance was 9.7 pS at -100 mV and 3.9 pS at 100 mV when measured in symmetrical 100 mM K(+) solutions. Second, single channels frequently showed no openings during depolarization but nevertheless revealed bursts of openings during repolarization. This type of gating may explain the inward rectification of HERG currents. To test this hypothesis, we used a three-closed state kinetics model and obtained rate constants from fits to macropatch data. Results from the model are consistent with rapid inactivation from closed states as a significant source of HERG rectification.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10409198     DOI: 10.1152/ajpheart.1999.277.1.H199

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  40 in total

1.  Differential effects of amino-terminal distal and proximal domains in the regulation of human erg K(+) channel gating.

Authors:  C G Viloria; F Barros; T Giráldez; D Gómez-Varela; P de la Peña
Journal:  Biophys J       Date:  2000-07       Impact factor: 4.033

2.  Effects of premature stimulation on HERG K(+) channels.

Authors:  Y Lu; M P Mahaut-Smith; A Varghese; C L Huang; P R Kemp; J I Vandenberg
Journal:  J Physiol       Date:  2001-12-15       Impact factor: 5.182

3.  Gating currents associated with intramembrane charge displacement in HERG potassium channels.

Authors:  David R Piper; Anthony Varghese; Michael C Sanguinetti; Martin Tristani-Firouzi
Journal:  Proc Natl Acad Sci U S A       Date:  2003-08-19       Impact factor: 11.205

4.  Drug binding to aromatic residues in the HERG channel pore cavity as possible explanation for acquired Long QT syndrome by antiparkinsonian drug budipine.

Authors:  Eberhard P Scholz; Edgar Zitron; Claudia Kiesecker; Sonja Lueck; Sven Kathöfer; Dierk Thomas; Slawomir Weretka; Simon Peth; Volker A W Kreye; Wolfgang Schoels; Hugo A Katus; Johann Kiehn; Christoph A Karle
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2003-10-14       Impact factor: 3.000

Review 5.  The HERG K+ channel: progress in understanding the molecular basis of its unusual gating kinetics.

Authors:  Jamie I Vandenberg; Allan M Torres; Terence J Campbell; Philip W Kuchel
Journal:  Eur Biophys J       Date:  2003-09-10       Impact factor: 1.733

6.  Molecular basis of slow activation of the human ether-a-go-go related gene potassium channel.

Authors:  Rajesh N Subbiah; Catherine E Clarke; David J Smith; JingTing Zhao; Terence J Campbell; Jamie I Vandenberg
Journal:  J Physiol       Date:  2004-06-04       Impact factor: 5.182

7.  Mapping the sequence of conformational changes underlying selectivity filter gating in the K(v)11.1 potassium channel.

Authors:  David T Wang; Adam P Hill; Stefan A Mann; Peter S Tan; Jamie I Vandenberg
Journal:  Nat Struct Mol Biol       Date:  2010-12-19       Impact factor: 15.369

Review 8.  Computational biology in the study of cardiac ion channels and cell electrophysiology.

Authors:  Yoram Rudy; Jonathan R Silva
Journal:  Q Rev Biophys       Date:  2006-07-19       Impact factor: 5.318

9.  Modulation of HERG gating by a charge cluster in the N-terminal proximal domain.

Authors:  J B Saenen; A J Labro; A Raes; D J Snyders
Journal:  Biophys J       Date:  2006-09-22       Impact factor: 4.033

10.  Inhibition of cardiac hERG potassium channels by tetracyclic antidepressant mianserin.

Authors:  Daniel Scherer; Katharina von Löwenstern; Edgar Zitron; Eberhard P Scholz; Ramona Bloehs; Sven Kathöfer; Dierk Thomas; Alexander Bauer; Hugo A Katus; Christoph A Karle; Claudia Kiesecker
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2008-05-06       Impact factor: 3.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.